Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Soriano, Vincent (57208312072)"

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    European recommendations for the clinical use of HIV drug resistance testing: 2011 update
    (2011)
    Vandamme, Anne-Mieke (35380737400)
    ;
    Camacho, Ricardo J. (57220486186)
    ;
    Ceccherini-Silberstein, Francesca (55882691600)
    ;
    De Luca, Andrea (7201948233)
    ;
    Palmisano, Lucia (8377254700)
    ;
    Paraskevis, Dimitrios (6603346862)
    ;
    Paredes, Roger (35410114800)
    ;
    Poljak, Mario (55142297400)
    ;
    Schmit, Jean-Claude (7103116821)
    ;
    Soriano, Vincent (57208312072)
    ;
    Walter, Hauke (7201498954)
    ;
    Sönnerborg, Anders (7005483848)
    ;
    Ait-Khaled, Mounir (6602905195)
    ;
    Albert, Jan (7201985763)
    ;
    Åsjö, Birgitta (7005985660)
    ;
    Bacheler, Lee (7003397436)
    ;
    Banhegyi, Denes (7004220250)
    ;
    Boucher, Charles (47160966300)
    ;
    Brun-Vézinet, Françoise (7006721524)
    ;
    Clotet, Bonaventura (7102349252)
    ;
    De Béthune, Marie-Pierre (6601984236)
    ;
    De Wit, Stéphane (35398225800)
    ;
    Dressler, Stephan (44160919700)
    ;
    Elston, Rob (57213448760)
    ;
    Gatell, José (19834919200)
    ;
    Geretti, Anna Maria (6701366859)
    ;
    Gerstoft, Jan (7005184715)
    ;
    Günthard, Huldrych F. (7005951278)
    ;
    Hall, William W. (7402629230)
    ;
    Hazuda, Daria (55403994000)
    ;
    Horban, Andrzej (57200769993)
    ;
    Jevtovic, Djordje (55410443900)
    ;
    Kaiser, Rolf (56898513600)
    ;
    Lataillade, Max (14041856400)
    ;
    Lundgren, Jens D. (35307337700)
    ;
    Marlowe, Natalia (6603377804)
    ;
    Maroldo, Laura (6504796213)
    ;
    Miller, Michael (55492790800)
    ;
    Nielsen, Claus (16407574900)
    ;
    Perno, Carlo Federico (35380302400)
    ;
    Petropoulos, Chris (35464017000)
    ;
    Phillips, Andrew (35372648800)
    ;
    Schapiro, Jonathan (29567538500)
    ;
    Schuurman, Rob (56898703600)
    ;
    Simen, Birgitte B. (6507224712)
    ;
    Stephan, Christoph (56261424000)
    ;
    Stürmer, Martin (6603811497)
    ;
    Suni, Jukka (7006140974)
    ;
    Teofilo, Eugenio (8103702300)
    ;
    Tsertsvadze, Tengiz (6603035261)
    ;
    Westby, Mike (6603884483)
    ;
    Yerly, Sabine (35228206200)
    ;
    Youle, Mike (7006018199)
    The European HIV Drug Resistance Guidelines Panel, established to make recommendations to clinicians and virologists, felt that sufficient new information has become available to warrant an update of its recommendations, explained in both pocket guidelines and this full paper. The Panel makes the following recommendations concerning the indications for resistance testing: for HIV-1 (i) test earliest sample for protease and reverse transcriptase drug resistance in drug-naive patients with acute or chronic infection; (ii) test protease and reverse transcriptase drug resistance at virologic failure, and other drug targets (integrase and envelope) if such drugs were part of the failing regimen; (iii) consider testing for CCR5 tropism at virologic failure or when a change of therapy has to be made in absence of detectable viral load, and in the latter case test DNA or last detectable plasma RNA; (iv) consider testing earliest detectable plasma RNA when a successful nonnucleoside reverse transcriptase inhibitor-containing therapy was inappropriately interrupted; (v) genotype source patient when postexposure prophylaxis is considered; for HIV-2, (vi) consider resistance testing where treatment change is needed after treatment failure. The Panel recommends genotyping in most situations, using updated and clinically evaluated interpretation systems. It is mandatory that laboratories performing HIV resistance tests take part regularly in external quality assurance programs, and that they consider storing samples in situations where resistance testing cannot be performed as recommended. Similarly, it is necessary that HIV clinicians and virologists take part in continuous education and discuss problematic clinical cases. Indeed, resistance test results should be used in the context of all other clinically relevant information for predicting therapy response.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The global spread of HIV-1 subtype B epidemic
    (2016)
    Magiorkinis, Gkikas (13408749100)
    ;
    Angelis, Konstantinos (56244957400)
    ;
    Mamais, Ioannis (54398898000)
    ;
    Katzourakis, Aris (6505851563)
    ;
    Hatzakis, Angelos (35371482000)
    ;
    Albert, Jan (7201985763)
    ;
    Lawyer, Glenn (27169140300)
    ;
    Hamouda, Osamah (6602677243)
    ;
    Struck, Daniel (24448531300)
    ;
    Vercauteren, Jurgen (23974986100)
    ;
    Wensing, Annemarie (6508292380)
    ;
    Alexiev, Ivailo (24400977400)
    ;
    Åsjö, Birgitta (7005985660)
    ;
    Balotta, Claudia (7004511267)
    ;
    Gomes, Perpétua (12241342900)
    ;
    Camacho, Ricardo J. (57220486186)
    ;
    Coughlan, Suzie (7003282845)
    ;
    Griskevicius, Algirdas (23488497500)
    ;
    Grossman, Zehava (7005752420)
    ;
    Horban, Anders (59826132200)
    ;
    Kostrikis, Leondios G. (6701410435)
    ;
    Lepej, Snjezana J. (8561186400)
    ;
    Liitsola, Kirsi (6602136869)
    ;
    Linka, Marek (6603398285)
    ;
    Nielsen, Claus (16407574900)
    ;
    Otelea, Dan (16158062400)
    ;
    Paredes, Roger (35410114800)
    ;
    Poljak, Mario (55142297400)
    ;
    Puchhammer-Stöckl, Elizabeth (7004072273)
    ;
    Schmit, Jean Claude (7103116821)
    ;
    Sönnerborg, Anders (7005483848)
    ;
    Staneková, Danica (6603431600)
    ;
    Stanojevic, Maja (57828665700)
    ;
    Stylianou, Dora C. (56962238800)
    ;
    Boucher, Charles A.B. (47160966300)
    ;
    Nikolopoulos, Georgios (15832379300)
    ;
    Vasylyeva, Tetyana (55897557600)
    ;
    Friedman, Samuel R. (57214036860)
    ;
    van de Vijver, David (56898780500)
    ;
    Angarano, Gioacchino (7007111846)
    ;
    Chaix, Marie-Laure (7003547342)
    ;
    de Luca, Andrea (57210754620)
    ;
    Korn, Klaus (57899379300)
    ;
    Loveday, Clive (57203028475)
    ;
    Soriano, Vincent (57208312072)
    ;
    Yerly, Sabine (35228206200)
    ;
    Zazzi, Mauricio (57226221788)
    ;
    Vandamme, Anne-Mieke (35380737400)
    ;
    Paraskevis, Dimitrios (6603346862)
    Human immunodeficiency virus type 1 (HIV-1) was discovered in the early 1980s when the virus had already established a pandemic. For at least three decades the epidemic in the Western World has been dominated by subtype B infections, as part of a sub-epidemic that traveled from Africa through Haiti to United States. However, the pattern of the subsequent spread still remains poorly understood. Here we analyze a large dataset of globally representative HIV-1 subtype B strains to map their spread around the world over the last 50 years and describe significant spread patterns. We show that subtype B travelled from North America to Western Europe in different occasions, while Central/Eastern Europe remained isolated for the most part of the early epidemic. Looking with more detail in European countries we see that the United Kingdom, France and Switzerland exchanged viral isolates with non-European countries than with European ones. The observed pattern is likely to mirror geopolitical landmarks in the post-World War II era, namely the rise and the fall of the Iron Curtain and the European colonialism. In conclusion, HIV-1 spread through specific migration routes which are consistent with geopolitical factors that affected human activities during the last 50 years, such as migration, tourism and trade. Our findings support the argument that epidemic control policies should be global and incorporate political and socioeconomic factors. © 2016 The Authors
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The global spread of HIV-1 subtype B epidemic
    (2016)
    Magiorkinis, Gkikas (13408749100)
    ;
    Angelis, Konstantinos (56244957400)
    ;
    Mamais, Ioannis (54398898000)
    ;
    Katzourakis, Aris (6505851563)
    ;
    Hatzakis, Angelos (35371482000)
    ;
    Albert, Jan (7201985763)
    ;
    Lawyer, Glenn (27169140300)
    ;
    Hamouda, Osamah (6602677243)
    ;
    Struck, Daniel (24448531300)
    ;
    Vercauteren, Jurgen (23974986100)
    ;
    Wensing, Annemarie (6508292380)
    ;
    Alexiev, Ivailo (24400977400)
    ;
    Åsjö, Birgitta (7005985660)
    ;
    Balotta, Claudia (7004511267)
    ;
    Gomes, Perpétua (12241342900)
    ;
    Camacho, Ricardo J. (57220486186)
    ;
    Coughlan, Suzie (7003282845)
    ;
    Griskevicius, Algirdas (23488497500)
    ;
    Grossman, Zehava (7005752420)
    ;
    Horban, Anders (59826132200)
    ;
    Kostrikis, Leondios G. (6701410435)
    ;
    Lepej, Snjezana J. (8561186400)
    ;
    Liitsola, Kirsi (6602136869)
    ;
    Linka, Marek (6603398285)
    ;
    Nielsen, Claus (16407574900)
    ;
    Otelea, Dan (16158062400)
    ;
    Paredes, Roger (35410114800)
    ;
    Poljak, Mario (55142297400)
    ;
    Puchhammer-Stöckl, Elizabeth (7004072273)
    ;
    Schmit, Jean Claude (7103116821)
    ;
    Sönnerborg, Anders (7005483848)
    ;
    Staneková, Danica (6603431600)
    ;
    Stanojevic, Maja (57828665700)
    ;
    Stylianou, Dora C. (56962238800)
    ;
    Boucher, Charles A.B. (47160966300)
    ;
    Nikolopoulos, Georgios (15832379300)
    ;
    Vasylyeva, Tetyana (55897557600)
    ;
    Friedman, Samuel R. (57214036860)
    ;
    van de Vijver, David (56898780500)
    ;
    Angarano, Gioacchino (7007111846)
    ;
    Chaix, Marie-Laure (7003547342)
    ;
    de Luca, Andrea (57210754620)
    ;
    Korn, Klaus (57899379300)
    ;
    Loveday, Clive (57203028475)
    ;
    Soriano, Vincent (57208312072)
    ;
    Yerly, Sabine (35228206200)
    ;
    Zazzi, Mauricio (57226221788)
    ;
    Vandamme, Anne-Mieke (35380737400)
    ;
    Paraskevis, Dimitrios (6603346862)
    Human immunodeficiency virus type 1 (HIV-1) was discovered in the early 1980s when the virus had already established a pandemic. For at least three decades the epidemic in the Western World has been dominated by subtype B infections, as part of a sub-epidemic that traveled from Africa through Haiti to United States. However, the pattern of the subsequent spread still remains poorly understood. Here we analyze a large dataset of globally representative HIV-1 subtype B strains to map their spread around the world over the last 50 years and describe significant spread patterns. We show that subtype B travelled from North America to Western Europe in different occasions, while Central/Eastern Europe remained isolated for the most part of the early epidemic. Looking with more detail in European countries we see that the United Kingdom, France and Switzerland exchanged viral isolates with non-European countries than with European ones. The observed pattern is likely to mirror geopolitical landmarks in the post-World War II era, namely the rise and the fall of the Iron Curtain and the European colonialism. In conclusion, HIV-1 spread through specific migration routes which are consistent with geopolitical factors that affected human activities during the last 50 years, such as migration, tourism and trade. Our findings support the argument that epidemic control policies should be global and incorporate political and socioeconomic factors. © 2016 The Authors

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback